Deals
Sickle Cell Drug Maker Global Blood Therapeutics Draws Takeover Interest
- Shares leapt as much as 41% following the Bloomberg report
- California company makes drug to treat sickle cell disease
This article is for subscribers only.
Global Blood Therapeutics Inc., which makes a drug for sickle cell disease, is attracting takeover interest, according to people familiar with the matter, sending shares up as much as 41%.
Some large pharmaceutical companies are studying a potential deal, the people said, asking not to be identified because the information is private. The company is working with advisers to evaluate the potential interest, they said. There’s no certainty it will lead to a transaction, the people added.